ABVC Biopharma Inc (ABVC) — Cash Flow Reinvestment Rate

Latest as of September 2024: 2.92x

ABVC Biopharma Inc (ABVC) has a Cash Flow Reinvestment Rate of 2.92x as of September 2024, reinvesting $501.62K (capex $3.00 plus investments $501.61K) from operating cash flow of $171.72K. See ABVC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.92x
(Capex + Investments) / Operating CF

Total Reinvested

$501.62K
Capex + Investments

Operating Cash Flow

$171.72K
USD

Capital Expenditures

$3.00
USD

ABVC Biopharma Inc Cash Flow Reinvestment Rate (2003–2015)

Historical reinvestment intensity for ABVC Biopharma Inc across 4 annual periods. For the full cash flow conversion analysis, see how efficiently does ABVC Biopharma Inc generate cash.

Annual Cash Flow Reinvestment Rate for ABVC Biopharma Inc (2003–2015)

Year-by-year capital reinvestment analysis for ABVC Biopharma Inc. See ABVC Biopharma Inc (ABVC) flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.00x $0.00 $3.36K $0.00 ▼ -100.0%
2014 16.73x $19.55K $1.17K $19.55K
2006 0.00x $0.00 $24.45K $0.00
2003 0.00x $0.00 $355.00 $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow